Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenza Conteduca

Showing results (71-80 of 157) with videos related to

Pageof 16
Sort By:
Annals of Surgical Oncology|September 20, 2014
High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancerLorena Rossi, Matteo Santoni, Simon J Crabb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2023
Immunogenomic Landscape of Neuroendocrine Prostate CancerBhavneet Bhinder, Alison Ferguson, Michael Sigouros, et al.
International Journal of Molecular Sciences|August 12, 2023
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate CancerMaria Concetta Cursano, Emilio Francesco Giunta, Emanuela Scarpi, et al.
Oncotarget|December 29, 2016
Vitamin D status among long-term survivors of testicular cancerGiuseppe Schepisi, Silvia De Padova, Emanuela Scarpi, et al.
Frontiers in Endocrinology|March 13, 2019
Psychosocial Issues in Long-Term Survivors of Testicular CancerGiuseppe Schepisi, Silvia De Padova, Delia De Lisi, et al.
The Prostate|June 29, 2019
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamideCristian Lolli, Delia De Lisi, Vincenza Conteduca, et al.
Endocrine-Related Cancer|August 17, 2016
Androgen receptor signaling pathways as a target for breast cancer treatmentElisabetta Pietri, Vincenza Conteduca, Daniele Andreis, et al.
JCO Precision Oncology|February 1, 2022
Multimodal Approach to Outcome Prediction in Metastatic Castration-Resistant Prostate Cancer by Integrating Functional Imaging and Plasma DNA AnalysisVincenza Conteduca, Emanuela Scarpi, Federica Matteucci, et al.
BMC Medicine|February 1, 2022
Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxelGiorgia Gurioli, Vincenza Conteduca, Nicole Brighi, et al.
Frontiers in Oncology|August 9, 2021
Melphalan as a Promising Treatment for BRCA-Related Ovarian CarcinomaVincenza Conteduca, Emanuela Scarpi, Alberto Farolfi, et al.
Pageof 16

Showing results (71-80 of 157) with videos related to

Sort By:
Pageof 16
Annals of Surgical Oncology|September 20, 2014
High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancerLorena Rossi, Matteo Santoni, Simon J Crabb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2023
Immunogenomic Landscape of Neuroendocrine Prostate CancerBhavneet Bhinder, Alison Ferguson, Michael Sigouros, et al.
International Journal of Molecular Sciences|August 12, 2023
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate CancerMaria Concetta Cursano, Emilio Francesco Giunta, Emanuela Scarpi, et al.
Oncotarget|December 29, 2016
Vitamin D status among long-term survivors of testicular cancerGiuseppe Schepisi, Silvia De Padova, Emanuela Scarpi, et al.
Frontiers in Endocrinology|March 13, 2019
Psychosocial Issues in Long-Term Survivors of Testicular CancerGiuseppe Schepisi, Silvia De Padova, Delia De Lisi, et al.
The Prostate|June 29, 2019
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamideCristian Lolli, Delia De Lisi, Vincenza Conteduca, et al.
Endocrine-Related Cancer|August 17, 2016
Androgen receptor signaling pathways as a target for breast cancer treatmentElisabetta Pietri, Vincenza Conteduca, Daniele Andreis, et al.
JCO Precision Oncology|February 1, 2022
Multimodal Approach to Outcome Prediction in Metastatic Castration-Resistant Prostate Cancer by Integrating Functional Imaging and Plasma DNA AnalysisVincenza Conteduca, Emanuela Scarpi, Federica Matteucci, et al.
BMC Medicine|February 1, 2022
Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxelGiorgia Gurioli, Vincenza Conteduca, Nicole Brighi, et al.
Frontiers in Oncology|August 9, 2021
Melphalan as a Promising Treatment for BRCA-Related Ovarian CarcinomaVincenza Conteduca, Emanuela Scarpi, Alberto Farolfi, et al.
Pageof 16